The State Drugs Control section has issued orders stopping the merchantability of Coldrif cough syrup successful Kerala, Health Minister Veena George said present connected Saturday.
The Drugs Control section took this measurement pursuing reports from extracurricular the State that immoderate samples from SR 13 batch of Coldrif cough syrup from Sresan Pharma’s Kanchipuram portion successful Tamil Nadu contained diethylene glycol (DEG) supra permissible limits.
According to the preliminary accusation gathered by the Drugs Control department, nary banal from Batch SR 13 of Coldrif syrup has been sold successful the State, the connection said. However, a full prohibition connected the merchantability of the said cause was being enforced successful the State arsenic an added precautionary measure.
Coldrif cough syrup is being sold done 8 distributors successful Kerala and each person been alerted to halt the organisation and sale. Medical stores crossed the State person besides been alerted to the merchantability ban.
The drugs power section is conducting inspections crossed the State. Samples of Coldrif arsenic good arsenic different brands of cough medicines are being collected for testing. Directions person besides been issued to cod and trial samples of the cough syrup that 5 pharma companies are manufacturing successful Kerala.
Coldrif syrup is not distributed by Kerala State Medical Services Corporation Ltd., the connection said.
The Drug Controller General of India (DCGI) had issued a directive connected Friday that doctors should not prescribe cough syrup to children beneath 2 years of age. Pharmacies person been directed not to merchantability cough syrup adjacent erstwhile determination is simply a prescription.
The directive said that cough medications, if prescribed for children supra 5 years, should beryllium connected the ground of objective evaluation, with adjacent supervision and strict adherence to due dosing.

7 months ago
2



